A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation
Open Access
- 9 October 2025
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 109 (1) , 1-16
Abstract
Tumor necrosis factor-alpha and interleukin-6 are proinflammatory cytokines involved in several autoimmune diseases, including rheumatoid arthritis. AlthouKeywords
Funding Information
- Pasteur Institute of Iran (1226)
This publication has 65 references indexed in Scilit:
- Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practiceRheumatology, 2007
- Pathogenesis of Rheumatoid Arthritis: Targeting CytokinesAnnals of the New York Academy of Sciences, 2005
- VADAR: a web server for quantitative evaluation of protein structure qualityNucleic Acids Research, 2003
- The N‐end rule pathway of protein degradationGenes to Cells, 1997
- LIGPLOT: a program to generate schematic diagrams of protein-ligand interactionsProtein Engineering, Design and Selection, 1995
- Verification of protein structures: Patterns of nonbonded atomic interactionsProtein Science, 1993
- Assessment of protein models with three-dimensional profilesNature, 1992
- Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassayJournal of Immunological Methods, 1987
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982
- Thermostability and Aliphatic Index of Globular ProteinsThe Journal of Biochemistry, 1980